Conclusion Tirzepatides approval as the first drug for OSA expands treatment options for patients with both obesity and sleep apnea
L-carnitine intake was related to a significant reduction in fasting plasma glucose, HbA1c, and HOMA-IR in individuals with cardiovascular risk factors in comparison with control groups (85)
A 2026 UK review of the May 2026 UCSF Annals of Neurology study showing "normal" but lower active B12 is linked to slower thinking and more white-matter brain injury, NICE NG239, the homocysteineDNA-methylation mechanism that suppresses hippocampal neurotrophins, the VITACOG brain-atrophy trial, pernicious anaemia, metformin and PPI depletion and why replacing the B12 comes first, not a peptide Read the full review Metabolic Neuropsychiatry & Cognitive Health 20 May 2026 Dihexa & GLP-1 Drugs (Ozempic, Wegovy, Mounjaro) and the Brain: The 2026 UK Review Do GLP-1 drugs like Ozempic, Wegovy and Mounjaro protect the brain or cause brain fog
But these injections are currently illegal to buy in the United States and are linked to potentially serious side effects
2011;6(1):e164703